[引用][C] N-of-1 trials as a bioequivalence method to assess local medicines in resources limited countries: the case of anti-hypertensive medicines in Ethiopia
CM Alemayehu - 2019 - espace.library.uq.edu.au
Background: The ability to provide quality assured affordable drugs in my country of Ethiopia
is limited by insufficient medicines regulation, particularly a bioequivalence (BE) evidence …
is limited by insufficient medicines regulation, particularly a bioequivalence (BE) evidence …